From: Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG
Variables | Total cohort (n = 1887) | cTnT group (n = 971) | hs-cTnT group (n = 916) | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | P | OR | 95%CI | P | OR | 95%CI | P | |
Age (y) | 1.052 | 1.012–1.094 | 0.011 | 1.055 | 0.997–1.116 | 0.064 | 1.049 | 0.994–1.108 | 0.080 |
Female (n, %) | 1.513 | 0.793–2.889 | 0.209 | 1.252 | 0.480–3.265 | 0.646 | 1.794 | 0.742–4.333 | 0.194 |
Weight (kg) | 0.985 | 0.957–1.014 | 0.310 | 0.982 | 0.942–1.024 | 0.395 | 0.988 | 0.949–1.029 | 0.563 |
Height (cm) | 0.984 | 0.945–1.024 | 0.422 | 0.965 | 0.911–1.022 | 0.223 | 1.001 | 0.946–1.060 | 0.961 |
NYHA classification (n, %) | 2.425 | 1.562–3.766 | 0.000 | 2.552 | 1.329–4.901 | 0.005 | 2.321 | 1.286–4.191 | 0.005 |
Types of CAD (n, %) | 1.231 | 0.776–1.951 | 0.377 | 2.256 | 1.129–4.509 | 0.021 | 0.720 | 0.363–1.427 | 0.347 |
Hypertention (n, %) | 0.859 | 0.455–1.620 | 0.638 | 2.097 | 0.612–7.179 | 0.238 | 0.499 | 0.213–1.169 | 0.109 |
Diabetes (n, %) | 1.450 | 0.781–2.694 | 0.239 | 1.512 | 0.630–3.626 | 0.354 | 1.409 | 0.584–3.398 | 0.446 |
Cerebrovascular disease (n, %) | 0.210 | 0.050–0.871 | 0.032 | 0.292 | 0.067–1.261 | 0.099 | 0.000 | 0.000–0.000 | 0.997 |
Cr (μmol/l) | 1.004 | 1.001–1.007 | 0.013 | 1.005 | 1.000–1.010 | 0.069 | 1.003 | 1.000–1.007 | 0.076 |
Ccr (ml/min/1.73 m2) | 0.975 | 0.962–0.988 | 0.000 | 0.971 | 0.951–0.991 | 0.005 | 0.978 | 0.961–0.995 | 0.010 |
LVEF (%) | 0.934 | 0.908–0.961 | 0.000 | 0.926 | 0.083–0.970 | 0.001 | 0.938 | 0.904–0.974 | 0.001 |
Number of diseased vessels (n) | 1.071 | 0.539–2.126 | 0.845 | 2.542 | 0.426–15.184 | 0.306 | 0.757 | 0.362–1.585 | 0.461 |
Peripheral vascular disease (n, %) | 4.296 | 1.470–12.556 | 0.008 | 3.466 | 0.770–15.608 | 0.105 | 5.86 | 1.256–27.349 | 0.024 |
Emergency operation (n, %) | 6.096 | 2.602–14.284 | 0.000 | 11.143 | 2.943–42.187 | 0.000 | 4.398 | 1.427–13.559 | 0.010 |
Combined valvulardisease (n, %) | 0.669 | 0.237–1.890 | 0.448 | 0.629 | 0.083–4.753 | 0.653 | 0.649 | 0.190–2.217 | 0.490 |
COPD (n, %) | 0.805 | 0.109–5.956 | 0.831 | 0.000 | 0.000–0.000 | 0.998 | 1.283 | 0.167–9.834 | 0.811 |
Atrial flutter and fibrillation (n, %) | 0.652 | 0.088–4.808 | 0.674 | 1.389 | 0.181–10.666 | 0.752 | 0.000 | 0.000–0.000 | 0.998 |
Pulmonary hypertension (n, %) | 0.978 | 0.345–2.769 | 0.967 | 0.000 | 0.000–0.000 | 0.998 | 1.068 | 0.356–3.199 | 0.907 |
Previous PCI (n, %) | 1.601 | 0.562–4.561 | 0.378 | 1.533 | 0.199–11.804 | 0.681 | 1.585 | 0.459–5.470 | 0.466 |
BMI (kg/m2) | 0.960 | 0.870–1.060 | 0.424 | 0.988 | 0.860–1.135 | 0.864 | 0.934 | 0.810–1.077 | 0.348 |
Renal failure (n, %) | 9.978 | 3.614–27.551 | 0.000 | 11.006 | 2.226–54.407 | 0.003 | 9.253 | 2.471–34.646 | 0.001 |
Euroscore II (%) | 1.574 | 1.342–1.846 | 0.000 | 1.815 | 1.414–2.330 | 0.000 | 1.437 | 1.166–1.770 | 0.001 |
Myocardial injury classification (n, %) | 2.049 | 1.542–2.722 | 0.000 | 3.564 | 2.105–6.035 | 0.000 | 1.963 | 1.322–2.915 | 0.001 |